Publications by authors named "C Wasylyk"

Claim this Profile
T
TTLL12 has a potential oncogenic activity, suppression of ligation of nitrotyrosine to the C-terminus of detyrosinated α-tubulin, that can be overcome by molecules identified by screening a compound library.
Amit Deshpande, Jan Brants, Christine Wasylyk, Onno van Hooij, Gerald W Verhaegh, Bohdan Wasylyk

PLoS One· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preferential Response of Basal-Like Head and Neck Squamous Cell Carcinoma Cell Lines to EGFR-Targeted Therapy Depending on -Driven Oncogenic Addiction.
Sylvie Job, Aurélien de Reyniès, Betty Heller, Amélie Weiss, Eric Guérin, Christine Wasylyk, Bohdan Wasylyk

Cancers (Basel)· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
X
XRP44X, an Inhibitor of Ras/Erk Activation of the Transcription Factor Elk3, Inhibits Tumour Growth and Metastasis in Mice.
Kostyantyn Semenchenko, Christine Wasylyk, Henry Cheung, Yves Tourrette, Peter Maas, Bohdan Wasylyk

PLoS One· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human Papillomavirus-related tumours of the oropharynx display a lower tumour hypoxia signature.
Elodie Hanns, Sylvie Job, Pierre Coliat, Christine Wasylyk, Ludivine Ramolu, Bohdan Wasylyk

Oral Oncol· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The oncogenic MicroRNA Hsa-miR-155-5p targets the transcription factor ELK3 and links it to the hypoxia response.
E Douglas Robertson, Christine Wasylyk, Tao Ye, Alain C Jung, Bohdan Wasylyk

PLoS One· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis